Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528157) titled 'Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression' on April 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Care Provider, Outcomes Assessor).

Primary Sponsor: Stanford University

Condition: Major Depressive Disorder Treatment Resistant Depression

Intervention: Device: Personalized iTBS Device: Non-Personalized iTBS

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: June 1, 2026

Target Sample Size: 80

Countries of R...